Are you living with Adult-Onset Leukoencephalopathy with Axonal Spheroids and Pigmented Glia (ALSP)?

Learn about the status of ongoing research in ALSP:

Participant Enrollment Complete

ignite logo

A clinical study of the investigational
treatment iluzanebart (VGL101)

Currently Recruiting Participants

illuminate logo

A natural history study of the disease
.

Are you living with Adult-Onset Leukoencephalopathy with Axonal Spheroids and Pigmented Glia (ALSP) or have you been diagnosed with a gene variant in the CSF1R gene?

Learn about the status of ongoing research in ALSP:

Participant Enrollment Complete

ignite logo

A clinical study of the investigational
treatment iluzanebart (VGL101)

Currently Recruiting Participants

illuminate logo

A natural history study of the disease

Vigil Neuroscience, a company dedicated to improving the lives of people living with neurodegenerative diseases, is developing a new potential therapy for ALSP called iluzanebart (VGL101). If you're interested in participating in either study or would like more information, we'd love to hear from you.

vigil-footer full color-R